WallStreetZenWallStreetZen

NASDAQ: TLSA
Tiziana Life Sciences Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TLSA

Based on 1 analyst offering 12 month price targets for Tiziana Life Sciences Ltd

Min Forecast
$7.00+566.67%
Avg Forecast
$7.00+566.67%
Max Forecast
$7.00+566.67%

Should I buy or sell TLSA stock?

Based on 1 analyst offering ratings for Tiziana Life Sciences Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TLSA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates TLSA as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -12.86% per year. Learn More

Be the first to know when Wall Street analysts revise their TLSA stock forecasts and price targets.

TLSA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-22

1 of 1

Forecast return on equity

Is TLSA forecast to generate an efficient return?

Company
N/A
Industry
25.06%
Market
177.77%

Forecast return on assets

Is TLSA forecast to generate an efficient return on assets?

Company
N/A
Industry
23.99%

TLSA earnings per share forecast

What is TLSA's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.17
Avg 2 year Forecast
-$0.18
Avg 3 year Forecast
-$0.19

TLSA revenue forecast

What is TLSA's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$99.6M

TLSA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TLSA$1.05$7.00+566.67%Strong Buy
ANTX$3.38$9.00+166.27%Strong Buy
ARMP$3.37$15.00+345.10%Buy
KRRO$8.49$18.00+112.01%Strong Buy
NKTX$1.80$11.67+548.17%Strong Buy
View Top Biotech Stocks

Tiziana Life Sciences Stock Forecast FAQ

Is Tiziana Life Sciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TLSA) stock is to Strong Buy TLSA stock.

Out of 1 analyst, 1 (100%) are recommending TLSA as a Strong Buy, 0 (0%) are recommending TLSA as a Buy, 0 (0%) are recommending TLSA as a Hold, 0 (0%) are recommending TLSA as a Sell, and 0 (0%) are recommending TLSA as a Strong Sell.

If you're new to stock investing, here's how to buy Tiziana Life Sciences stock.

What is TLSA's earnings growth forecast for 2026-2028?

(NASDAQ: TLSA) Tiziana Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.8%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.78%.

Tiziana Life Sciences's earnings in 2026 is -$18,431,000.On average, 4 Wall Street analysts forecast TLSA's earnings for 2026 to be -$20,895,983, with the lowest TLSA earnings forecast at -$21,257,506, and the highest TLSA earnings forecast at -$20,245,243. On average, 3 Wall Street analysts forecast TLSA's earnings for 2027 to be -$22,125,159, with the lowest TLSA earnings forecast at -$21,257,506, and the highest TLSA earnings forecast at -$22,775,899.

In 2028, TLSA is forecast to generate -$23,354,334 in earnings, with the lowest earnings forecast at -$22,438,478 and the highest earnings forecast at -$24,041,226.

What is TLSA's revenue growth forecast for 2026-2030?

(NASDAQ: TLSA) Tiziana Life Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.13%.

Tiziana Life Sciences's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast TLSA's revenue for 2026 to be $0, with the lowest TLSA revenue forecast at $0, and the highest TLSA revenue forecast at $0. On average, 3 Wall Street analysts forecast TLSA's revenue for 2029 to be $0, with the lowest TLSA revenue forecast at $0, and the highest TLSA revenue forecast at $0.

In 2030, TLSA is forecast to generate $11,998,319,381 in revenue, with the lowest revenue forecast at $11,527,737,980 and the highest revenue forecast at $12,350,803,528.

What is TLSA's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: TLSA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 23.99%.

What is TLSA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TLSA price target, the average TLSA price target is $7.00, with the highest TLSA stock price forecast at $7.00 and the lowest TLSA stock price forecast at $7.00.

The Wall Street analyst predicted that Tiziana Life Sciences's share price could reach $7.00 by Sep 22, 2027. The average Tiziana Life Sciences stock price prediction forecasts a potential upside of 566.67% from the current TLSA share price of $1.05.

What is TLSA's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: TLSA) Tiziana Life Sciences's current Earnings Per Share (EPS) is -$0.16. On average, analysts forecast that TLSA's EPS will be -$0.17 for 2026, with the lowest EPS forecast at -$0.18, and the highest EPS forecast at -$0.17. On average, analysts forecast that TLSA's EPS will be -$0.18 for 2027, with the lowest EPS forecast at -$0.18, and the highest EPS forecast at -$0.19. In 2028, TLSA's EPS is forecast to hit -$0.19 (min: -$0.19, max: -$0.20).

What is TLSA's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: TLSA) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.